Rare diseases
Investigational molecules
Locations
Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults
ItalyPhase 3 Study of Mitapivat to Reduce Transfusions in Children with Alpha or Beta Transfusion‑Dependent Thalassemia
ItalyPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
ItalyPhase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer
ItalyEffect of denosumab versus zoledronic acid on erosion progression in patients with erosive hand osteoarthritis and osteoporosis: a randomized controlled trial
ItalyAdvanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
ItalyEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
ItalyStudy of dupilumab added to standard care in adults hospitalized for COPD exacerbation to reduce readmissions, emergency visits, and death
ItalyRandomized Placebo‑Controlled Trial of Colchicine to Slow Disease Progression in Adults with Amyotrophic Lateral Sclerosis
ItalyEfficacy and Safety of Berotralstat for Preventing Angioedema Attacks in Patients with Acquired Angioedema due to C1 Inhibitor Deficiency
ItalyStudy of Sodium Valproate and Lenvatinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
ItalyPremedication with dexamethasone to prevent interstitial lung disease in breast cancer patients receiving trastuzumab deruxtecan
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
